What question did this study set out to answer?

To investigate the association between low anti-Mullerian hormone (AMH) levels and the risk of MASLD in midlife women.

March 1, 2026Open Access

Low anti-Mullerian hormone in reproductive age is associated with MASLD in midlife

Key Points

To investigate the association between low anti-Mullerian hormone (AMH) levels and the risk of MASLD in midlife women.
Cross-sectional analysis of AMH levels in reproductive-aged women
Assessment of MASLD prevalence in midlife
Control for metabolic comorbidities
Women with low AMH levels have over 2-fold higher odds of MASLD in midlife
Association remains significant after adjusting for metabolic conditions

Abstract

Low AMH levels in reproductive-aged women conferred a more than 2-fold higher odds of prevalent MASLD in midlife, independent of metabolic comorbidities. AMH levels may therefore serve as a valuable marker of MASLD risk in young women.

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper